CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 11 No. 6
Pages: 1  2  3  
Next
 

Ovarian Cancer Surgical Practice Guidelines

By

William Hoskins, MD
Committee Chairperson, Deputy Physician in Chief, Disease Management Teams, Chief Gynecology Service, Department of Surgery, Avon Chair in Gynecologic Oncology Research Memorial Sloan-Kettering Cancer Center, New York, New York
Laurel Rice, MD
Associate Professor, Department of Obstetrics/Gynecology, University of Virginia Health Science Center, Charlottesville, Virginia
Stephen Rubin, MD
Professor and Director, Division of Gynecologic Oncology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

| June 1, 1997

Scope and Format of Guidelines

The Society of Surgical Oncology surgical practice guidelines focus on the signs and symptoms of primary cancer, timely evaluation of the symptomatic patient, appropriate preoperative evaluation for extent of disease, and role of the surgeon in diagnosis and treatment. Separate sections on adjuvant therapy, follow-up programs, or management of recurrent cancer have been intentionally omitted. Where appropriate, perioperative adjuvant combined-modality therapy is discussed under surgical management. Each guideline is presented in minimal outline form as a delineation of therapeutic options.

Since the development of treatment protocols was not the specific aim of the Society, the extensive development cycle necessary to produce evidence-based practice guidelines did not apply. We used the broad clinical experience residing in the membership of the Society, under the direction of Alfred M. Cohen, md, Chief, Colorectal Service, Memorial Sloan-Kettering Cancer Center, to produce guidelines that were not likely to result in significant controversy.

Following each guideline is a brief narrative highlighting and expanding on selected sections of the guideline document, with a few relevant references. The current staging system for the site and approximate 5-year survival data are also included.

The Society does not suggest that these guidelines replace good medical judgment. That always comes first. We do believe that the family physician, as well as the health maintenance organization director, will appreciate the provision of these guidelines as a reference for better patient care.


Society of Surgical Oncology Practice Guidelines: Ovarian Cancer

Symptoms and Signs

    Early-stage disease
  • Symptoms:
    1. Abdominal swelling (self-palpation of mass)
    2. Abdominal pain
    3. Urinary symptoms
    4. Abnormal vaginal bleeding
    5. Fatigue
  • Signs:
    1. Palpation of a mass on pelvic examination (Risk of malignancy increases if mass is solid, irregular, fixed, or bilateral.)
    2. Identification of an ovarian mass on ultrasound, CT scan, or MRI (Risk of cancer increases with increasing size of mass, with a complex mass, and with increasing age of patient.)
    3. Elevation of CA-125 above 35 units (CA-125 may be less than 35 units in up to 50% of stage I cancers.)
    Advanced-stage disease
  • Symptoms:
    1. Abdominal swelling (secondary to masses or ascites)
    2. Abdominal pain
    3. Urinary symptoms
    4. Gastrointestinal symptoms
    5. Abnormal vaginal bleeding
    6. Fatigue
    7. Respiratory distress
  • Signs:
    1. Abdominal distension
    2. Palpation of masses on pelvic or abdominal eamination
    3. Ultrasound, CT scan, or MRI evidence of ascites and/or complex pelvic and/or abdominal masses
    4. X-ray evidence of pleural effusion

Evaluation of the Symptomatic Patient

    Early-stage disease
  • Complete history and physical examination
  • Serum CA-125 level
  • Serum beta hCG, AFP, and LDH in women less than 30 years old
  • Chest x-ray
  • Pelvic ultrasound (Morphology index and color flow Doppler may be helpful but are of unproven benefit.)
  • CT scan and MRI usually add little to the evaluation of early disease and should not be considered routine.
  • Uterine curettage or biopsy if patient has abnormal vaginal bleeding
  • In women over age 45, stool guaiac should be performed. Consider colon evaluation (barium enema and sigmoidoscopy or colonoscopy) if symptoms warrant. Consider upper gastrointestinal x-ray studies or endoscopy if symptoms warrant.
  • Mammography screening as appropriate for age
    Advanced-stage disease
  • Complete history and physical examination
  • Serum CA-125 level
  • Serum beta hCG, AFP, and LDH in women less than 30 years old
  • Chest x-ray
  • CT scan (or MRI) of the abdomen and pelvis
  • Uterine curettage or biopsy if patient has abnormal vaginal bleeding
  • Stool guaiac for women over age 45. Consider colon evaluation (barium enema and sigmoidoscopy or colonoscopy) if symptoms warrant. Consider upper gastrointestinal x-rays or endoscopy if symptoms warrant.
  • Mammography screening as appropriate for age
    Appropriate timeliness of surgical referral
  • Evaluation with due diligence for the above symptoms or signs
Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy